Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06455046
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-06
Brief Title:
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-06
First Submit QC Date:
June 6 2024
Study First Post Date:
2024-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-06
Last Update Post Date:
2024-06-12
Last Update Post Date Type:
ACTUAL